In search of preclinical robustness

Ian S Peers; Peter R Ceuppens; Chris Harbron

doi:10.1038/nrd3849

In search of preclinical robustness

Nat Rev Drug Discov. 2012 Oct;11(10):733-4. doi: 10.1038/nrd3849.

Authors

Ian S Peers¹, Peter R Ceuppens, Chris Harbron

Affiliation

¹ AstraZeneca 13F41 Mereside, Alderley Park, Macclesfield SK10 4TG, UK. [email protected]

PMID: 23023666
DOI: 10.1038/nrd3849

Abstract

Systematic engagement of statisticians in preclinical research could help address the weaknesses that are undermining the likelihood of subsequent success in drug discovery and development.

MeSH terms

Animals
Biomedical Research / methods
Biomedical Research / statistics & numerical data
Drug Discovery* / methods
Drug Discovery* / statistics & numerical data
Drug Evaluation, Preclinical* / methods
Drug Evaluation, Preclinical* / statistics & numerical data
Drug Industry / methods
Drug Industry / statistics & numerical data
Humans